Company news
Optiscan Imaging Limited news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Appointment of new non-executive director
May 6, 2021
OIL March 2021 Quarterly Report and Appendix 4C
April 28, 2021
Appointment of new non-executive chair
April 19, 2021
Appointment of New Non-executive Chair
April 18, 2021
Appendix 4D and Financial Statements - 31 December 2020
February 25, 2021
OIL breast cancer study to commence next stage - revised
February 8, 2021
Optiscan breast cancer study to commence next stage
February 8, 2021
OIL December 2020 Quarterly Report and Appendix 4C
January 28, 2021
Carl Zeiss Meditec AG Product Orders
January 12, 2021
Appointment of Taiwan Distributor
December 15, 2020
OIL 2020 AGM Presentation
November 26, 2020
TGA Approval for CONVIVO and Sterile Sheath In Australia
November 9, 2020
OIL September 2020 Quarterly Report and Appendix 4C
October 29, 2020
US FDA Regulatory Approval update
October 8, 2020
OptiScan Capital Raising
September 24, 2020
Optiscan Capital Raising
September 21, 2020
Pause in Trading
September 21, 2020
Appendix 4E and 2020 Annual Report
August 31, 2020
New North American & Expanded Asia Pacific Distribution
August 28, 2020
OIL June 2020 Quarterly Report and Appendix 4C
July 31, 2020
2 X China Tender Success for FIVE2 (ViewnVivo)
July 27, 2020
Government grant to support Melbourne Dental School Trial
July 19, 2020
Achievement of Final Milestone in Carl Zeiss Agreement
May 4, 2020
OIL March 2020 Quarterly Report and Appendix 4C
April 30, 2020
Corporate Update
March 19, 2020
Appendix 4D and Financial Statements - 31 December 2019
February 28, 2020
Corporate Update - January 2020
January 30, 2020
Appointment of Second China Distributor
December 5, 2019
2019 AGM Presentation
November 27, 2019
Optiscan Market Update
November 24, 2019
OIL initiates FDA feedback for Oral Cancer 510(k) submission
November 3, 2019
Appointment of new China Distributor
October 15, 2019
Leading Aus & US Hospital Collaboration to trial OIL device
September 23, 2019
Appendix 4E and 2019 Annual Report
August 30, 2019
Optiscan System Approved for Prestigious Cancer Centre Trial
August 21, 2019
Investor Presentation - June 2019
June 14, 2019
Optiscan Secures Strong Support in $1.70 M Capital Raising
June 13, 2019
OptiScan March 2019 Presentation
March 13, 2019
Appendix 4D and Financial Statements - 31 Dec 2018
February 28, 2019
Collaboration Agreement with Summit Biomedical Imaging LLC
February 26, 2019
OptiScan technology used in research at major cancer centre
February 25, 2019
Reinstatement to Official Quotation
November 6, 2018
ZEISS achieves another milestone on regulatory pathway
November 6, 2018
Suspension from Official Quotation
November 1, 2018
Clinical Trial - Assessment of Breast Cancer Margin
October 14, 2018
Appendix 4E and 2018 Annual Report
August 31, 2018
Market Update
June 13, 2018
ZEISS CONVIVO and Appointment of Interim Executive Chairman
May 31, 2018
Appendix 4D and Financial Statements - 31 Dec 2017
February 28, 2018
Update on CEO Recruitment and Interim Management
February 15, 2018
Decks
The 5 newest of 38 decks. Every deck is listed under its year.
- Bell Potter Healthcare Conference (November 2026)
Conference · 11 slides · Nov 17, 2026
- Investor Presentation (December 2025)
Investor deck · 37 slides · Dec 4, 2025
- Shareholder Meeting (November 2025)
Shareholder meeting · 40 slides · Nov 14, 2025
- ASX SMIDcaps Conference, Sydney 2025
Conference · 22 slides · Sep 24, 2025
- Corporate Update (April 2025)
Corporate update · 26 slides · Apr 10, 2025